CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹32 Cr | ₹32 Cr | ₹54 Cr | ₹77 Cr | ₹55 Cr |
What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹32 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹54 Cr |
Mar2021 | ₹77 Cr |
Mar2020 | ₹55 Cr |
How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹32 Cr | -0.71 | |
Mar2023 | ₹32 Cr | -40.93 | |
Mar2022 | ₹54 Cr | -29.74 | |
Mar2021 | ₹77 Cr | 40.32 | |
Mar2020 | ₹55 Cr | - |
Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹20,800.2 Cr | 2.1% | -5.9% | 40% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -1.4% | -7.1% | 48% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 1.5% | -2.1% | 63% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -3.5% | -5.2% | 18% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -3.9% | -10.1% | 10.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -0.3% | -7.3% | 52.2% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 2.1% |
-5.9% |
40% |
SENSEX | -2.4% |
-4.2% |
19.5% |
You may also like the below Video Courses